Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;32(4):e14033.
doi: 10.1111/jvh.14033. Epub 2024 Nov 6.

Long-Term Follow-Up of Neuropsychiatric Symptoms After Sustained Virological Response to Interferon-Free and Interferon-Based Hepatitis C Virus Treatment

Affiliations

Long-Term Follow-Up of Neuropsychiatric Symptoms After Sustained Virological Response to Interferon-Free and Interferon-Based Hepatitis C Virus Treatment

Meike Dirks et al. J Viral Hepat. 2025 Apr.

Abstract

Chronic hepatitis C virus (HCV) infection can be associated with neuropsychiatric symptoms like fatigue and cognitive impairment, independent of the liver status. The present study aims to assess changes in the pattern and extent of neuropsychological symptoms after successful treatment with interferon (IFN)-based and IFN-free therapy. HCV-infected patients who underwent neuropsychological assessment in previous studies were invited to a follow-up examination. Patients were grouped according to the treatment status: Sustained virological response (SVR) after IFN treatment (IFN SVR, n = 14) or after therapy with direct acting antivirals (DAA SVR, n = 28) or ongoing HCV infection (HCV RNA+, n = 11). A group of 33 healthy controls served as reference. Patients completed self-report questionnaires addressing health-related quality of life (HRQoL), mood and sleep quality and a neuropsychological test battery including tests of memory and attention (Luria's list of words, PSE test, cancelling "d" test, Word-Figure-Memory Test and computer-based test battery for the assessment of attention [TAP]). At baseline, all three patient groups had worse fatigue, depression, anxiety and HRQoL scores compared to healthy controls. Longitudinal analysis revealed that fatigue and mood slightly improved in all patient groups over time, while HRQoL improved in SVR patients but not in HCV RNA+ patients. Memory test results improved significantly in all patient groups, irrespective of their virological status. In contrast, the attention test results showed no clear change from baseline to follow-up. Our data can be considered as a hint that HCV eradication-independent of therapy regimen-does not substantially ameliorate neuropsychiatric symptoms in HCV-afflicted patients.

Keywords: follow‐up; hepatitis C virus; neuropsychiatric symptoms; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
(A) Fatigue Impact Scale (FIS) results in each patient group for baseline (BL) and follow‐up (FU). Median results are marked with red dots. (B) SF‐36 sumscore in each patient group for baseline (BL) and follow‐up (FU). Median results are marked with red dots.
FIGURE 2
FIGURE 2
Word–Figure–Memory Test, change of the z‐score for words between baseline BL (=0) and follow‐up (FU).

References

    1. Yeoh S. W., Holmes A. C. N., Saling M. M., Everall I. P., and Nicoll A. J., “Depression, Fatigue and Neurocognitive Deficits in Chronic Hepatitis C,” Hepatology International 12, no. 4 (2018): 294–304. - PubMed
    1. Poynard T., Cacoub P., Ratziu V., et al., “Fatigue in Patients With Chronic Hepatitis C,” Journal of Viral Hepatitis 9 (2002): 295–303. - PubMed
    1. Strauss E., Porto‐Ferreira F. A., de Almeida‐Neto C., and Teixeira M. C., “Altered Quality of Life in the Early Stages of Chronic Hepatitis C Is Due to the Virus Itself,” Clinics and Research in Hepatology and Gastroenterology 38, no. 1 (2014): 40–45. - PMC - PubMed
    1. Forton D., Weissenborn K., Bondin M., and Cacoub P., “Expert Opinion on Managing Chronic HCV in Patients With Neuropsychiatric Manifestations,” Antiviral Therapy 23, no. Suppl 2 (2018): 47–55. - PubMed
    1. Fletcher N. F. and McKeating J. A., “Hepatitis C Virus and the Brain,” Journal of Viral Hepatitis 19 (2012): 301–306. - PubMed

LinkOut - more resources